This podcast aims to bring you a daily summary of the most relevant news in Pharma and BioTech. Check our website at: https://www.buzzsprout.com/2189790
…
continue reading
BioTech News Podcasts
We quickly breakdown the latest news in biotech. Fast Facts. Big Breakthroughs.
…
continue reading
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
…
continue reading
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
…
continue reading
Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
…
continue reading
A weekly audio digest of the most important news in drug development affecting the pharmaceutical and biotech industry
…
continue reading
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
…
continue reading
Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.
…
continue reading
Welcome to Biotech Bulls & Breakthroughs! This brand new podcast from BioPharmCatalyst explores the dynamic world of biotech investing alongside long-time biotech trader Sheff from Sheff Station. Each month, we will be discussing current events in the biotech industry and how these events impact investors, as well as a discussion of upcoming catalysts in the biotech space.
…
continue reading
Deep Tech Germany is your front-row seat to the boldest breakthroughs emerging from Germany, Austria, and Switzerland—the DACH region—where advanced research, scientific innovation, and venture capital converge. As part of the Startuprad.io™ network, we spotlight the founders, engineers, scientists, and investors fueling Europe’s deep tech ecosystems. 🌍 Hosted in English for a global audience, this show connects you to the people and platforms building the future of: AI, quantum computing, p ...
…
continue reading
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
…
continue reading
The Vance Crowe Podcast is a thought-provoking and engaging show where Vance Crowe, a former Director of Millennial Engagement for Monsanto, and X-World Banker, interviews a variety of experts and thought leaders from diverse fields. Vance prompts his guests to think about their work in novel ways, exploring how their expertise applies to regular people and sharing stories and experiences. The podcast covers a wide range of topics, including agriculture, technology, social issues, and more. ...
…
continue reading
Welcome to the Ennovation Podcast, where we bring you the latest trends, insights and expertise in life sciences and regulatory affairs.
…
continue reading
Welcome to The Pharma Podcast - Insights from industry experts and business leaders about important and current topics in Canadian Pharma, Biotech and Medtech.
…
continue reading
Podcast hosted by investigative writer and researcher Whitney Webb
…
continue reading
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of pe ...
…
continue reading
Powerful stories of biotechnology breakthroughs, the people they help, and the global problems they solve.
…
continue reading
Welcome to PWS United, a podcast for the Prader-Willi Syndrome community, brought to you by PWSA | USA. This podcast gives the latest news in research, advocacy, and family support by bringing together staff, volunteers, PWS treatment specialists, biotech and pharmaceutical representatives, caregivers, family members, and individuals with PWS. Our goal is to connect education, awareness, and resources with those living with PWS and their supporters. Join us in our mission to enhance the qual ...
…
continue reading
4
Mad Science: The Genetic Crossroad With Anna Kavanaugh
Anna Kavanaugh | Living Eden Media, LLC
70
28
Anna Kavanaugh hosts the weekly radio series, "Mad Science: The Genetic Crossroad." The program aims to raise awareness and provide education about genetically modified organisms (GMO), in the world food supply and the practices of the GM biotech industry. The series is dedicated to all issues surrounding GM foods, its usage and ramifications thereof. Anna is a writer, producer, journalist and advocate. She is the founder of the (AKCF) Anna Kavanaugh Charitable Foundation. Her original novel ...
…
continue reading
Big ideas and big debates, explained through intimate conversations with the compelling personalities who shape them. AI and biotech. Higher education and health care. Climate and sustainability. Politics and the media. Culture and culture wars. Hosted by Boston Globe columnist Shirley Leung.
…
continue reading
Bloomberg's Joe Weisenthal and Tracy Alloway explore the most interesting topics in finance, markets and economics. Join the conversation every Monday and Thursday.
…
continue reading
Hosted by Melissa Lee and a roundtable of top traders, “Fast Money” breaks through the noise of the day, to deliver the actionable news that matters most to investors. Fast Money airs weeknights at 5p ET on CNBC. Visit http://fastmoney.cnbc.com for additional information.
…
continue reading
Matt breaks down relevant biotech stocks, analyzing their data and determining if they are a good investment.
…
continue reading
The Oppenheimer Let’s Talk Future Podcast explores a variety of market perspectives, bringing our firm’s financial thought leaders directly to you.
…
continue reading
News and Analysis of the Biotech and Pharma Industry for Investors and Executives.
…
continue reading
The FYI - For Your Innovation Podcast offers an intellectual discussion on recent developments across disruptive innovation—driven by research, news, controversies, companies, and technological breakthroughs. Hosted by ARK Invest, ARK and guests provide a unique perspective on how to best understand disruptive innovation.
…
continue reading
BioBiz Buzz offers exclusive insights into the biotech, pharma, and medtech industries through interviews with top executives and visionaries. Providing thought-provoking podcasts covering topics such as scientific advancements, emerging technologies, and market trends, to keep listeners informed about the latest developments in life sciences. Disclaimer https://biobizbuzz.com/disclaimer/
…
continue reading
Tech Uncensored, Crucial Analysis in Tech, is a bi-weekly podcast brought to you by Altitude Accelerator. Hosted by Hessie Jones, we explore emerging news, and relevant topics that startups care about. We speak to subject matter experts, founders and advisors in Investment: Venture Capital, Equity Crowdfunding, and across Industry: Clean Tech, Biotech, Generative AI, Blockchain, Web3, Privacy, Security etc. who weigh in on the challenges that startup founders face today, as well as the profo ...
…
continue reading
Women Who Rock GSA is your front-row seat to the women redefining entrepreneurship and innovation in the DACH region. As part of the award-winning Startuprad.io™ network, this sub-podcast celebrates female founders, investors, and trailblazers from Germany, Austria, and Switzerland—all delivered in English for a global audience. 🎧 Ranked among the Top 20 Global Entrepreneurship Podcasts on Apple, this series uncovers the untold stories, strategic insights, and powerful journeys of women tran ...
…
continue reading
The Center for Investment Excellence features educational insights across asset classes and investment themes designed to give you the tools you need to empower better decisions and build stronger portfolios.
…
continue reading
BloodStream is an entertaining and informational podcast for the bleeding disorders community. Each week, hemophilia patient Patrick James Lynch and former non-profit director Amy Board are joined by advocacy leaders, medical experts, and other guests to discuss the latest news, scientific advancements, policy initiatives, and so much more. Subscribe wherever you listen, or search BloodStream Podcast on YouTube to catch every episode there. Produced by Believe Limited. Presenting sponsor: Ta ...
…
continue reading
30-year financial insider, Frank Curzio, breaks down the mainstream media headlines, exposes the TRUTH about what’s really moving the markets, and brings you exclusive intel and actionable investment ideas directly from Wall Street pros.
…
continue reading
Podcasts from The National Bureau of Asian Research (NBR) covering the critical issues that leaders need to understand – because the decisions they make matter and the stakes are high.
…
continue reading
Mondays: Tom Deep Dives. Tuesday and Wednesdays: In Depth Interviews. Thursdays: The Tom Bilyeu show. Fridays: Tom Bilyeu Live! Uncover the truth behind the headlines and memes in an unbiased pursuit of what’s real. From interviews and reactions to debates on the most important topics of the day, this podcast will challenge everything you know about current events, the economy, culture, and more. Tom Bilyeu’s Impact Theory helps you thrive in our complex world. Hosted by Tom Bilyeu, a promin ...
…
continue reading
Your go-to source for expert insight on the MBA admissions journey—from school selection to application tips. Each week, hosts Graham Richmond and Alex Brown deliver MBA Wire Taps—real-time analysis of admissions news and applicant profile reviews. Special episodes feature in-depth conversations with admissions directors, deans, and industry experts. Whether you're choosing the right schools or refining your application, our podcast helps you make informed, strategic decisions every step of ...
…
continue reading
Welcome to The Art of Digitalisation, a podcast brought to you by one of the most digital countries on earth, e-Estonia. Directly from the heart of the e-Estonia secret headquarters. Or briefing centre as we actually call it. In every episode, we bring you digitalisation experts from across the globe, sharing their expertise and advice on how they transformed businesses, governments, and more, using innovation through technology. Whether you’re taking your first steps on your own digitalisat ...
…
continue reading
Accessing (and keeping) talent in today’s biotechnology sector isn’t easy. There’s no question that biotech, life sciences, and the medical field in general experienced massive acceleration since March 2020. More treatments have been approved, biotech investment reached record heights, and thousands of new companies entered the landscape, heralding unprecedented growth in just about every aspect of the sector – bio health, bioenergy, bio-industrial, and agri-bio.In this podcast, Rob Henderso ...
…
continue reading
I talked about the weed killer round Up and the positives and negatives associated with it.
…
continue reading
1
Equity
TechCrunch, Mary Ann Azevedo, Kell, Theresa Loconsolo, Rebecca Bellan, Kirsten Korosec, Devin Coldewey, Margaux MacColl
398664
The intersection of technology, startups, and venture capital touches everything now. That’s why Equity, TechCrunch's flagship podcast, digs into the business of startups for entrepreneurs and enthusiasts alike. Every Wednesday and Friday, TechCrunch reporters keep you up-to-date on the world of business, technology, and venture capital. Equity is ranked the No.2 podcast in the Top 100 Venture Capital All time leaderboard on Goodpods—As well as No.17 for the Top 100 Finance All time chart an ...
…
continue reading
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
…
continue reading
The podcast that gives you slices from the life sciences companies revolutionizing the industry. Produced by Slice of Media, Inc.
…
continue reading
The Deal podcast network brings The Deal’s award winning coverage in M&A, activist investing, private equity and restructuring to your airwaves. With a suite of offerings, including Activist Investing Today (hosted by Senior Editor Ronald Orol), Drinks With The Deal (hosted by Senior Writer David Marcus and Senior Reporter Bill Meagher), Behind The Buyouts (hosted by Senior Reporters Steve Gelsi, Nikitha Sattiraju and Senior Writer Chris Nolter) and Fresh Start (hosted by Senior Reporter Ste ...
…
continue reading
1
Pharma and Biotech Daily: Navigating the Latest News in the Industry
0:54
0:54
Play later
Play later
Lists
Like
Liked
0:54
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Former FDA official Peter Marks criticized the agency's new risk-based COVID-19 vaccine framework, stating it contradicts the administration's transparency and science standards. The CDC's advisory committee recommended M…
…
continue reading
1
Should Billionaires Exist? The Brutal Truth About Money Printing, Inflation & the Rigged System | Tom Bilyeu Deep Dive
40:39
40:39
Play later
Play later
Lists
Like
Liked
40:39
Today, I am diving deep into a question that’s on everybody’s mind right now—should billionaires even exist? In this solo episode, I’m pulling back the curtain on the wealth gap, social mobility, and the hidden mechanics that are driving massive inequality in our world. I’ll walk you through the shocking numbers, break down how our financial system…
…
continue reading
1
Why US Banks Are Trying to Turn Themselves Into Super Apps
54:55
54:55
Play later
Play later
Lists
Like
Liked
54:55
Rohit Chopra is a former director of the Consumer Financial Protection Bureau, which was created in the aftermath of the 2008 financial crisis. In this episode, we speak with him about the current status of the CFPB under the Trump administration, and Rohit's experience while working at the bureau, including decisions made by regulators during the …
…
continue reading
1
MBA Wire Taps 435—705 GMAT, private equity. Architect in London. Enlisted military, 332 GRE.
35:52
35:52
Play later
Play later
Lists
Like
Liked
35:52
In this week's MBA Admissions podcast we began by discussing some of the recent activity on LiveWire; we followed this by highlighting a new article published by Clear Admit that summarizes the current situation for international students seeking visas to study in the United States. Graham noted Clear Admit’s summer series of webinars, which focuse…
…
continue reading
1
Pharma and Biotech Daily: FDA Rejections, Vaccine Approvals, and Industry Acquisitions
1:01
1:01
Play later
Play later
Lists
Like
Liked
1:01
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The FDA has rejected Capricor's therapy for Duchenne Muscular Dystrophy (DMD), causing shares to plunge due to insufficient evidence of effectiveness for cardiomyopathy associated with DMD. Lilly and Sarepta also received…
…
continue reading
1
Lewis Howes on The Skill You Need to Succeed in Today’s World (Fan Fav)
1:04:42
1:04:42
Play later
Play later
Lists
Like
Liked
1:04:42
Your life story begins as a child no matter who you are. Though our experiences are all uniquely different, pain and frustration from whatever reason usually leaves you scared, angry, and sometimes bitter. When Lewis Howes came face to face with his anger and rage, he got to work on understanding himself, his triggers and how he could improve every…
…
continue reading
1
Stocks Retreat From Records… And Bitcoin’s Fresh Record 7/11/25
43:51
43:51
Play later
Play later
Lists
Like
Liked
43:51
Stocks close out the week pulling back from record highs. How President Trump’s latest tariff escalations hit markets, and how a number of catalysts next week could fuel the recent rally, or pressure stocks to the downside. Plus Crypto cruising higher, as Bitcoin surges to fresh record highs. Why one Bitcoin bull sees the token heading to $1 millio…
…
continue reading
Gilead’s twice-yearly injectable PrEP, Yeztugo was recently approved by the FDA, but the story doesn’t end there. In this episode of The Biotech Brief, we explore how Gilead is leveraging global partnerships, generics, and regulatory streamlining to deliver Yeztugo to low- and middle-income countries without delay. Building on Episode 1, “Changing …
…
continue reading
1
HIVE Digital CEO details record hash rate growth and next targets
4:44
4:44
Play later
Play later
Lists
Like
Liked
4:44
HIVE Digital Technologies Ltd CEO Aydin Kilic talked with Proactive's Stephen Gunnion about the company’s rapid expansion in Bitcoin mining and new developments in AI data centers. Kilic explained that HIVE recently reached 12 exahash globally, a milestone achieved by acquiring and completing the Yguazú Paraguay site. "We brought on one exahash per…
…
continue reading
1
Baselode-Forum starts high-grade uranium drilling at Aberdeen project
4:10
4:10
Play later
Play later
Lists
Like
Liked
4:10
Forum Energy Metals Corp CEO Rebecca Hunter talked with Proactive's Stephen Gunnion about the latest drilling program at the Loki and Bjorn grids within the Aberdeen Project. Hunter explained that the Loki grid has become a high-priority exploration target due to significant indicators found in past drilling. She said, "We hit really strong clay al…
…
continue reading
1
Why Hugging Face's new robot is the Seinfeld of AI devices
30:45
30:45
Play later
Play later
Lists
Like
Liked
30:45
Hugging Face just launched Reachy Mini, an open source AI robot with big googly eyes and not much utility, and that’s kind of the charm. On this episode of Equity Kirsten Korosec, Max Zeff, and Anthony Ha break down the bot's debut, why it’s giving Seinfeld energy, and what it says about the future of open source hardware. Listen to the full episod…
…
continue reading
1
Millennial Potash achieves major milestone with $3M in DFC funding for Banio Project
6:15
6:15
Play later
Play later
Lists
Like
Liked
6:15
Millennial Potash Corp Chairman Farhad Abasov talked with Proactive's Stephen Gunnion about the US International Development Finance Corporation's commitment of up to US$3 million in development funding for the Banio Potash Project in Gabon.Abasov explained that the funding is structured as non-dilutive, interest-free support, representing a major …
…
continue reading
1
Digi Power X CEO discusses pivot to AI data centers powered by Bitcoin mining growth
12:17
12:17
Play later
Play later
Lists
Like
Liked
12:17
Digi Power X Inc CEO Michel Amar talked with Proactive's Stephen Gunnion about the company’s strategic pivot from Bitcoin mining to developing advanced AI data centers. Amar explained that Digi Power X currently operates four sites with about 100 megawatts dedicated to Bitcoin mining. The company has acquired a combined cycle gas power plant, trans…
…
continue reading
Layoffs in biopharma show no signs of slowing, with workforce reductions holding steady across the first two quarters of 2025. In this week’s episode of "The Top Line," Fierce Deputy Editor Andrea Park and Fierce Biotech Senior Editor Gabrielle Masson break down the latest layoff trends and how they compare to last year. Tune in for a look at the n…
…
continue reading
1
ATR: Farm Security is National Security? with Vance's worthy adversary John Kempf
46:14
46:14
Play later
Play later
Lists
Like
Liked
46:14
In this episode of the Ag Tribes Report, host Vance Crowe is joined by John Kempf, an Amish farmer from Northeast Ohio and founder of Advancing Eco Agriculture. They delve into the intriguing launch of an AI agronomist by Kempf's company, exploring the potential of AI in agriculture and its implications for the industry. The conversation also touch…
…
continue reading
1
What NYC's Most Powerful CEOs Think About Zohran Mamdani
44:19
44:19
Play later
Play later
Lists
Like
Liked
44:19
When socialist candidate Zohran Mamdani won the Democratic party's nomination for NYC mayor, top business leaders experienced a bout of hysteria. That's according to Kathy Wylde, the president and CEO of the non-profit organization the Partnership for New York City. Founded in 1979, the organization assembles the CEOs of some of the biggest employe…
…
continue reading
1
Deep State Drama: Epstein Cover-Up, Grok Goes Nazi, and Elon’s Real Mars Agenda | The Tom Bilyeu Show LIVE
1:24:45
1:24:45
Play later
Play later
Lists
Like
Liked
1:24:45
Welcome back to Impact Theory with Tom Bilyeu! In this episode, Tom dives headfirst into some of the timeliest and most controversial topics heating up the internet right now. From the persistent mysteries surrounding the Epstein files and the political whirlwind of Trump and Netanyahu, to the wilder side of AI with Grok’s out-of-control responses,…
…
continue reading
1
Dr. Erik Berntorp (the best-kept secret in vWD) and cancer podcasting legend, Matthew Zachary
48:38
48:38
Play later
Play later
Lists
Like
Liked
48:38
Dr. Erik Berntorp (medical doctor, researcher, and professor at Lund University in Sweden) joins us to discuss something special related to von willebrand disease and Matthew Zachary, award-winning Cancer Maverick, Keynote Speaker, and Pioneering Podcaster sits down with Patrick to chat all things advocacy and media! Presenting Sponsor: Takeda, vis…
…
continue reading
1
Insights from Pharma and Biotech: CRL Transparency, Acquisition Updates, and Digitization Strategies
1:28
1:28
Play later
Play later
Lists
Like
Liked
1:28
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The FDA has recently released over 200 complete response letters (CRLs) as part of its initiative to enhance transparency regarding the reasons behind the rejection of new drug and biologics applications. This effort reflec…
…
continue reading
1
How OMass Therapeutics is tackling congenital adrenal hyperplasia, a rare genetic disorder
34:27
34:27
Play later
Play later
Lists
Like
Liked
34:27
Ros Deegan is an industry leader and the CEO of OMass Therapeutics, an Oxford-based biotechnology company discovering medicines against highly-validated target ecosystems, such as membrane proteins or intracellular complexes. OMass’s MC2 program targeting Congenital Adrenal Hyperplasia, or CAH, is set to enter the clinic this year and in our interv…
…
continue reading
1
Software vs. Semiconductors… And Big Box Battle 7/10/25
43:47
43:47
Play later
Play later
Lists
Like
Liked
43:47
A divergence in the tech space, as software stocks trail the chipmakers. What it means for the broader market, and if the underperforming software sector can catch up. And speaking of underperforming, Target trailing Walmart in a major way over the past year. Why the big box retailers are heading in different directions, and what the Chartmaster se…
…
continue reading
1
360: NIH grant cuts, FDA transparency questions and biotech M&A
25:18
25:18
Play later
Play later
Lists
Like
Liked
25:18
On this week’s episode of the Readout LOUD: A closer look at the NIH’s grant-cutting legal playbook, a not-so-transparent transparency push by the FDA commissioner, and another big biotech acquisition. Our colleague Anil Oza joins us to unravel a previously unseen memo he obtained from HHS that lays out the legal framework being used to justify the…
…
continue reading
1
Lisata Therapeutics and GATC Health see collaboration as the way forward for drug development
10:52
10:52
Play later
Play later
Lists
Like
Liked
10:52
Lisata Therapeutics Inc CEO Dr David Mazzo and GATC Health chief business officer Tyrone Lam talked with Proactive's Stephen Gunnion about the companies' collaboration to advance a novel treatment for opioid use disorder. Mazzo explained that combining Lisata’s regulatory and clinical expertise with GATC’s MAT artificial intelligence platform allow…
…
continue reading
1
Manx Financial CEO on record 2024, Irish expansion and growth plans
7:46
7:46
Play later
Play later
Lists
Like
Liked
7:46
Manx Financial Group (AIM:MFX) CEO Douglas Grant talked with Proactive about the company’s record 2024 results and plans for continued expansion. Grant shared that Manx Financial Group delivered a 41% jump in profits last year, driven by three main growth areas: Conister Bank’s strong liquidity, Payment Assist’s accelerating lending volumes, and Ma…
…
continue reading
1
London BTC Company CEO on Bitcoin strategy and fresh funding
3:14
3:14
Play later
Play later
Lists
Like
Liked
3:14
London BTC Company Ltd (LSE:BTC, OTCQB:VINZF) CEO Hewie Rattray talked with Proactive's Stephen Gunnion about the company’s £1.5 million capital raise and how it plans to deploy these funds to build its Bitcoin holdings. Rattray explained that nearly all of the capital will be used to increase the company’s Bitcoin stack over the next six to twelve…
…
continue reading
1
Chesnara's £260m HSBC Life deal to boost dividends & cashflow
6:31
6:31
Play later
Play later
Lists
Like
Liked
6:31
Chesnara PLC (LSE:CSN) chief executive Steve Murray talked with Proactive's Stephen Gunnion about the company’s £260 million agreement to acquire HSBC Life UK’s insurance business. The deal, set to complete in early 2026, will see over 450,000 policyholders join Chesnara and bring approximately £4 billion of assets under administration.Murray said,…
…
continue reading
1
Fineqia's new yield-bearing ETP surpasses C$15M in assets
10:31
10:31
Play later
Play later
Lists
Like
Liked
10:31
Fineqia International Inc (CSE:FNQ, OTC:FNQQF) CEO Bundeep Singh Rangar talked with Proactive about the strong early traction of the Fineqia Bitcoin Yield ETP (YBTC). YBTC has quickly surpassed C$15 million in assets under management, driven by what Rangar described as a “triangulation” of factors: high demand for bitcoin, Europe’s regulatory frame…
…
continue reading
1
Savannah Resources CEO outlines way forward after £4.8M capital raise for Barroso lithium project
7:06
7:06
Play later
Play later
Lists
Like
Liked
7:06
Savannah Resources PLC (AIM:SAV, ETR:SAV, OTC:SAVNF) CEO Emanuel Proença talked with Proactive's Stephen Gunnion about the company’s progress at its Barroso Lithium Project in northern Portugal. Savannah Resources is a junior miner fully permitted to develop a lithium spodumene resource that Proença described as “the only sizable and competitive re…
…
continue reading
1
Georgina Energy targets gas growth after audit delay
6:58
6:58
Play later
Play later
Lists
Like
Liked
6:58
Georgina Energy PLC (LSE:GEX) chief financial officer Mark Wallace talked with Proactive's Stephen Gunnion about the company’s recent financial results delay and its strategic plans for natural gas development. Wallace explained that the delay was due to the complex reverse takeover of Mining, Minerals & Metals PLC and the subsequent re-listing pro…
…
continue reading
1
Oriole Resources unveils 1M oz gold target at Mbe project in Cameroon
3:35
3:35
Play later
Play later
Lists
Like
Liked
3:35
Oriole Resources PLC CEO Martin Rosser talked with Proactive's Stephen Gunnion about the company's announcement of a significant maiden exploration target at its Mbe project in Cameroon. The milestone was achieved in under nine months from the start of the maiden drilling. Rosser explained that the independent consultant Forge estimated a median to…
…
continue reading
1
Ep. 3: Stock Picking and Catalyst Research | Biotech Bulls & Breakthroughs Podcast
1:01:00
1:01:00
Play later
Play later
Lists
Like
Liked
1:01:00
In this episode, John Gagliano and Sheff discuss current trends in the biotech market, focusing on investment strategies, the importance of catalyst dates, and stock evaluation. Sheff shares insights on his watchlist for upcoming biotech plays, emphasizing the importance of due diligence in making informed investment decisions. The conversation hig…
…
continue reading
1
Assessing China’s Military and its Midcentury Goal
46:59
46:59
Play later
Play later
Lists
Like
Liked
46:59
In this episode of Asia Insight, NBR President Michael Wills is joined by Rear Admiral Mike Studeman (U.S. Navy, ret.) and Ms. Cathy Johnston as they assess the People's Liberation Army ahead of the Chinese Communist Party's goal to build a world-class military by 2049. Cathy Johnston spent 33 years in the Intel Community mostly focused on Asia. He…
…
continue reading
1
Pharmaceutical Superintelligence With Alex Zhavoronkov
1:30:32
1:30:32
Play later
Play later
Lists
Like
Liked
1:30:32
In this episode of FYI, Chief Futurist, Brett Winton, and Analyst Nemo Marjanovic speak with Alex Zhavoronkov, founder and CEO of Insilico Medicine. Together, they explore the promise of artificial intelligence in transforming the drug discovery process—cutting years off timelines and dramatically reducing costs. Alex shares Insilico’s journey from…
…
continue reading
1
Secrets, Scandals, and Space Invaders: What Trump, Epstein & an Alien Comet Have in Common | The Tom Bilyeu Show
1:13:11
1:13:11
Play later
Play later
Lists
Like
Liked
1:13:11
Welcome back to Impact Theory with Tom Bilyeu! In this episode, Tom and co-host Drew dive headfirst into a whirlwind of today’s most polarizing headlines and cultural debates. Get ready for a high-energy line-up that tackles everything from the baffling Epstein files controversy and Trump’s surprising Nobel Peace Prize nomination, to Supreme Court …
…
continue reading
1
How a Geopolitical Analyst Predicts the Outcome of War
44:29
44:29
Play later
Play later
Lists
Like
Liked
44:29
For investors, geopolitical risks are always lurking as a factor that could upend trades for obvious reasons. When war breaks out, it's crucial to have some kind of understanding of what it will mean for various markets (such as oil or grain) and how long the conflict can persist. But is there any way to analyze these things scientifically? Many pe…
…
continue reading
1
Say More Live: Dr. Kevin Churchwell of Boston Children’s Hospital
22:30
22:30
Play later
Play later
Lists
Like
Liked
22:30
It's a uniquely challenging time for our nation's medical community. The Trump administration has set its sites on slashing federal funding for healthcare and research by tens of billions of dollars, which could be catastrophic for the NIH and CDC. Funding is tenuous to say the least. Then there's mounting political pressure to restrict access to c…
…
continue reading
1
Pharma and Biotech Daily: Merck's Acquisition, Supreme Court Ruling, and Trump's Tariff Threats
1:04
1:04
Play later
Play later
Lists
Like
Liked
1:04
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Merck recently made a significant move in the pharmaceutical industry by acquiring Verona for $10 billion, gaining access to the commercial COPD drug Ohtuvayre. This acquisition is viewed as a strategic decision to offse…
…
continue reading
1
Ocean Power Technologies deploys AI-enabled PowerBuoy with AT&T 5G for Naval Postgraduate School
4:31
4:31
Play later
Play later
Lists
Like
Liked
4:31
Ocean Power Technologies CEO Philipp Stratmann joined Steve Darling from Proactive to announce the successful deployment of the company’s PowerBuoy® system in Monterey Bay, California, in support of the Naval Postgraduate School. This latest installation is part of a previously announced contract and represents a strategic leap forward in integrati…
…
continue reading
1
Nvidia’s Record $4 Trillion Market Cap… And Time For An Apple Turnover? 7/9/25
43:53
43:53
Play later
Play later
Lists
Like
Liked
43:53
Nvidia becomes the first company to cross the $4T market cap, as the chip giant helps fuel the Nasdaq to its own record high. How the semi surge is fueling the broader tech trade, and if the gains can continue. Plus Is it time for an Apple turnover? Why one Wall Street research firm thinks it’s time for Tim Cook to be replaced, and how a new chief …
…
continue reading
